These data suggested that embelin downregulating cFLIPL could enhance TRAIL sensitivity of breast cancer cells and the soluble TRAIL secretion by hUCMSCs could effectively increase the apoptosis of breast cancer cells. This evidence concerns the gene CFLAR and breast cancer.